03 · What You Need to Know
What Scientific and Social Value Actually Mean
Scientific Value and Social Value Are Related but Not Identical
The terms are sometimes used together as though they mean exactly the same thing. They overlap, but separating them can clarify ethical reasoning.
Scientific value
Concerns the contribution research can make to credible knowledge, understanding, methods, evidence, theory, or future inquiry.
Social value
Concerns the importance or usefulness of the knowledge for addressing health, welfare, policy, practice, or other needs relevant to people or communities.
CIOMS defines social value in health-related research in terms of the importance of the information a study is likely to produce. It explains that such value may arise from direct relevance to a significant health problem or from contributing to research likely to promote individual or public health.
The distinction should not be made artificially rigid. Knowledge with primarily scientific value today may contribute to substantial social value later. Basic research is an obvious example.
Value Matters Because Research Imposes Costs, Burdens, or Risks
The ethical argument for value begins with a simple question: why should this research be conducted at all?
Participants may contribute time, personal information, biological samples, inconvenience, or exposure to risk. Communities may provide access and trust. Institutions and funders allocate scarce resources. Researchers themselves invest effort that could have been directed elsewhere.
Some prospect of worthwhile knowledge helps justify those contributions.
CIOMS states this explicitly for health-related research involving humans: scientific and social value constitute the ethical justification for undertaking such research. Proposed studies should therefore be scientifically sound, build on an adequate prior knowledge base, and be likely to generate valuable information.
Belmont Connects Knowledge to the Ethical Assessment of Benefit
The Belmont Report uses somewhat different terminology but reaches related territory through beneficence and risk-benefit assessment.
Belmont recognizes that benefits of research can accrue not only to individual participants but also to society through knowledge gained from research. It also emphasizes that participant risks ordinarily receive special weight and that rights must remain protected.
Value therefore helps justify research, but it does not function as a simple exchange in which enough societal benefit permits unlimited risk to individuals.
Direct Participant Benefit Is Not Required in Every Study
One of the most important distinctions is between the value of the research and direct benefit to the person participating in it.
A healthy volunteer may participate in research offering no direct health benefit. A participant may complete interviews that improve understanding of a social phenomenon without personally gaining from the resulting knowledge. An observational study may benefit future decision-making without changing anything for the people whose data made the study possible.
Belmont explicitly recognizes research in which individual participants are not direct beneficiaries while knowledge gained may benefit others.
Researchers should therefore avoid presenting participation itself as personally beneficial when no direct benefit is reasonably expected.
Payment Is Not the Same as Research Benefit
Compensation, reimbursement, incentives, and research benefits perform different functions.
Payment may compensate participants for time or inconvenience, reimburse expenses, or provide an incentive for participation. It does not transform an otherwise valueless study into scientifically or socially valuable research.
Likewise, researchers should not inflate the ethical justification of a study by listing routine compensation as though it were evidence that the research itself benefits participants.
Social Value Does Not Mean Immediate Practical Impact
Some research has an obvious pathway to application. Other research contributes indirectly.
Basic research may clarify a mechanism whose practical significance becomes apparent years later. Methodological research may improve how future studies measure an outcome. Replication may establish whether an influential finding is robust. Exploratory work may identify patterns that later research investigates more rigorously.
Ethical value should therefore not be reduced to “Can someone use this finding tomorrow?”
CIOMS recognizes that socially valuable information may contribute to future research likely to promote health rather than directly changing practice itself.
Novelty Is Not the Same as Value
A study does not have to be unprecedented to be valuable.
Replication is the clearest example. Repeating or extending prior research can test reproducibility, evaluate generalizability, examine a different population, improve precision, or challenge an influential finding. None of those contributions requires claiming that nobody has ever asked the question before.
Novelty can contribute to value, but novelty for its own sake is not an ethical requirement. A new study that answers an irrelevant question poorly may have less value than a careful replication of evidence on which important decisions depend.
A Null or Negative Result Can Still Have Scientific Value
Value must be assessed prospectively rather than awarded only to studies that produce exciting findings.
If a well-designed study finds little evidence for an expected effect, that result may prevent ineffective practices, refine theory, improve estimates, redirect future research, or reveal that an influential assumption was unsupported.
Research would become badly distorted if ethical value depended on producing statistically significant or positive results. Researchers would have an ethical incentive to find what they hoped to find, which is approximately the opposite of what science needs.
Inconclusive Research Can Also Have Been Ethically Justified
A study may be well designed and ethically justified yet end inconclusively because recruitment is difficult, effects are more variable than anticipated, external events disrupt data collection, or the underlying phenomenon simply remains uncertain.
Research involves epistemic risk: researchers do not know in advance what they will discover or whether the evidence will be decisive.
The ethical question is therefore whether there was a reasonable prospect of generating valuable information when the study was undertaken and whether researchers responded appropriately as circumstances changed. Guaranteed usefulness is not a plausible requirement for inquiry.
Scientific Soundness Is Necessary to Realize Value
An important topic alone does not give a study social value.
CIOMS stresses that scientifically sound design is essential because information must be sufficiently reliable to serve the purpose used to justify the research. A study addressing a major health problem may still lack value if its methods cannot produce informative evidence.
The 2024 Declaration of Helsinki similarly requires scientifically sound and rigorous medical research likely to produce reliable, valid, and valuable knowledge and avoid research waste.
This is the ethical connection explored more directly when asking why poor research design can itself become an ethical problem.
Social Value Depends on Relevance, Not Merely Technical Quality
The reverse problem is also possible: a study can be technically excellent but ask a question or measure an outcome with little meaningful relevance.
CIOMS notes that even a well-designed late-phase clinical trial could lack social value if its endpoints are disconnected from clinical decision-making and therefore unlikely to influence practice.
This illustrates why scientific rigor and social value should not be collapsed. Good methods help ensure that the answer is credible. Social value asks whether obtaining that answer matters sufficiently in the relevant context.
Who Decides What Counts as Socially Valuable?
This is one of the more difficult questions because “social value” can sound objective while concealing judgments about whose problems matter.
Researchers, sponsors, funders, institutions, policymakers, participants, and communities may value different outcomes. A sponsor may prioritize a commercially promising intervention. A community may prioritize an unglamorous problem receiving little research attention. Researchers may favor theoretically interesting questions that have limited immediate application.
CIOMS notes that social value can vary with the significance of the health need, the expected merits and novelty of the approach, available alternatives, and other considerations. Its guidelines also emphasize community engagement in relevant contexts.
Social value should therefore be justified rather than merely asserted. Researchers should explain whose needs the research addresses, how the proposed knowledge could matter, and why the question warrants the burdens involved.
Value Cannot Legitimate Mistreatment or Injustice
Perhaps the most important limitation is that valuable research is not automatically ethical research.
CIOMS explicitly states that although scientific and social value provide the fundamental justification for undertaking health-related research, they cannot legitimate mistreatment or injustice toward participants or host communities.
A study can address an urgent problem and still use unacceptable recruitment, excessive risk, inadequate consent, unfair participant selection, or other ethically problematic practices.
This is why scientifically strong and valuable research can still be ethically unacceptable. Value is part of ethical justification, not a substitute for the rest of it.
The Amount of Value Needed Depends Partly on What the Research Asks of Others
Ethical justification is proportional.
A brief anonymous questionnaire with minimal burden does not require the same magnitude of anticipated social benefit as a high-risk intervention. As burdens and risks increase, the reasons for imposing them require correspondingly stronger scrutiny.
This does not provide a mathematical threshold. Belmont itself emphasizes that risk-benefit “balancing” is not ordinarily a precise quantitative calculation. The aim is a systematic and nonarbitrary assessment of whether the anticipated knowledge and other benefits justify what participants are being asked to bear.
